ProCE Banner Activity

Clinical Uptake of Precision Medicine Advances in NSCLC: A Case Study in RET Fusions


This poster, presented at ASCO Quality Care 2022, features an analysis HCP awareness and application of RET fusion testing and integration of recently approved selective RET inhibitors into practice for appropriate patients with advanced NSCLC.

Released: October 03, 2022

Expiration: October 02, 2023

No longer available for credit.


Additional Information


Krista Marcello

Senior Director,

Educational Strategy,

Hematology and Oncology

Clinical Care Options

Telephone: 315.600.7877